Read more here
FSHD UK
Fulcrum Therapeutics and Sanofi collaborate to commercialize Losmapimo
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy
Back to News